Oncology
Symposium
The future of tyrosin kinase inhibitors
Clinical
Aims : To describe the present and forthcoming tyrosine kinase inhibitors (TKIs) and their indications as well as to portray future developments up-to-the-minute.
Target audience :
Clinician, Oncologist, Pathologist, Pulmonologist
14:45
Understanding the mechanisms of TKIs: the cycle of inhibition and resistance
R. Rosell(Badalona (Barcelona), Spain)
COI
-
Description
1
4506
15:15
The future generations of TKIs
J. Cadranel(Paris Cedex 20, France)
COI
-
Description
2
4507
15:45
Re-purposing TKI treatment
M. Kolb(Hamilton (ON), Canada)
COI
3
4509
16:15
Panel discussion: led by speakers and chairs
4
. . .